Formulation Development and Evaluation Studies of Linezolid Inhaler in the Treatment of Tuberculosis
Abstract
The primary objective of this study was to prepare and evaluate a linezolid inhaler. Dry powder inhaler liposomes were formulated to investigate the efficacy of pulmonary delivery of Linezolid for tuberculosis. The liposomes were prepared using soya lecithin and cholesterol in different weight ratios, drug in a constant amount, and two different methods: physical dispersion and ethanol injection. The F9 formulation was characterized for physical and chemical properties such as vesicle size, shape, and zeta potential. The results of physical characterization, in vitro testing, and stability studies indicate that liposomes containing Linezolid can be used for the treatment of tuberculosis. The evaluated batch exhibited favorable physicochemical properties, with spherical liposomes having a mean size below 100 nm and high entrapment efficiency (98.8%). The prepared liposomal dry powder inhalers (DPIs) sustained drug release for up to 8 hours. Liposome stability was assessed 90 days after storage at room temperature, revealing its stability. The liposomal formulation had steady zeta potential, good entrapment efficiency, improved stability, and an extended drug release time. In conclusion, linezolid-loaded liposomal inhalers were successfully formulated.
Keywords:
Liposome, Dry powder inhaler, Tuberculosis, Linezolid, Cholesterol, Soya lecithinDOI
https://doi.org/10.25004/IJPSDR.2023.150605References
Tripathi KD. Essentials of Medical Pharmacology. Ed 7, Jaypee Brothers Medical Publishers, New Delhi, 2013, pp. 765 - 779.
Tripathi KD. Essentials of Medical Pharmacology. Ed 7, Jaypee Brothers Medical Publishers, New Delhi, 2013, pp. 752 - 764.
Benita S. Microencapsulation: Methods and Industrial Applications. Ed 2, Vol. 158, CRC Press, London, 2006, pp. 318.
Chaurasiya B, Zhao Y-Y. Dry Powder for Pulmonary Delivery: A Comprehensive Review. Pharm. 2020;13(1):31.
Chennakesavulu S, Mishra A, Sudheer A, Sowmya C, Reddy CS, Bhargav E. Pulmonary Delivery of Liposomal Dry Powder Inhaler Formulation for Effective Treatment of Idiopathic Pulmonary Fibrosis. Asian J Pharma Sci. 2018;13(1):91-100.
Paul S, Roy T, Bose A, Chatterjee D, Chowdhury VR, Rana M, Das A. Liposome Mediated Pulmonary Drug Delivery System: An Updated Review. Research J. Pharm. and Tech. 2021;14(3):1791-1796.
Radivojev S. Characterization of potential new dry powder inhaler formulations. M. S thesis. Graz Univ. of Technology; 2017.
Dhabale PN and C, Seervi. Simultaneous UV Spectrophotometric Method for Estimation of Metformin Hydrochloride in Tablet Dosage Form. Inter. J. Chem. Tech Res. 2010: 813 – 817.
J. Cooper and C. Gunn. Tutorial Pharmacy Powder flow and Compaction. Ed 12, CBS publishers, New Delhi, 1987, pp. 211 – 233.
Parashar V, Ahmad D, Gupta SP, Upmanyu N, and Parashar N. Formulation and Evaluation of Biodegradable Microspheres of Tinidazole. Int. J Drug Deliv. 2010; 2:238-241.
Mutalik S, Naha A, Usha AN, Anju P, Ranjith AK, Musmade P, Manoj K and Prasanna. Preparation, In Vitro, Preclinical, and Clinical Evaluation of Once-Daily Sustained Release of Tablets of Aceclofenac. Arch Pharm Res. 2007; 30:222 – 232.
Mallikarjuna Gouda M, Ramakrishna Shabaraya. A, Shantakmar. S.M. Development and Validation of Selective U.V. Spectrophotometric Analytical Method for Fluticasone Propionate Pure Sample. J Appl. Pharm. Sci. 2011;01(07):158-161.
Shivhare UD, Mathur VB, Bhusari KP. Formulation and Evaluation of Pentoxifylline Liposome Formulation. Dig. J Nanomater. Bios. 2009;4(4):857-862.
Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H. Ethanol Injection Method for Hydrophilic and Lipophilic Drug-loaded Liposome Preparation. J Liposome Res. 2009;20(3):228–43.
United States Pharmacopoeia, pp.2125-2127.
Janga KY, Jukanti R, Velpula A, Sunkavalli S, Bandari S, Kandadi P, Veerareddy PR. Bioavailability Enhancement of Zaleplon via Proliposomes: Role of Surface Charge. Eur J Pharm Biopharm. 2012;80(2):347-57. doi: 10.1016/j.ejpb.2011.10.010.
Krishna MC and Rabinarayan P, Formulation, and Evaluation of Acyclovir Liposomes, Int. Res. J Pharm. Biosci. 2017.
Singh N, Kushwaha P. Proliposomes: An Approach for the Development of Stable Liposome. Ars Pharm. 2019;60(4):231-240.
Muppidi K, Pumerantz AS, Wang J, Betageri G. Development and Stability Studies of Novel Liposomal Vancomycin Formulations. ISRN Pharm. 2012;636-743.
Published
Abstract Display: 536 
PDF Downloads: 483 
